# ZEPATIER

NDC: 0006-3074
Generic name: elbasvir and grazoprevir
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20160128

FDA application: NDA208261

## Active ingredients

- ELBASVIR: 50 mg/1
- GRAZOPREVIR ANHYDROUS: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3074"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3074
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=164dc02a-9180-426a-b8b5-04ab39d2bbd4